ArticleMolecular therapy. Oncology2026

Preclinical evaluation of triple-mutated oncolytic herpes virus expressing fusion-type interleukin 12 for malignant melanoma.

Miwako Iwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.